Scientists just discovered a new species of magic mushroom, Psilocybe ochraceocentrata, that appears to have shared a common ancestor with the popular Psilocybe cubensis some 1.5 million years ago.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Parex Resources Inc. ('Parex” or the 'Company”) (TSX: PXT) is pleased to announce that it has entered into a definitive agreement (the 'Arrangement Agreement') with Frontera Energy Corporation ...

I focus on AURA (Assets Underestimated, Resilient & Agentic) companies, which are undervalued due to market overreaction to AI disruption fears.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

ARR increased 31% year-over-year to $811 millionQ4 revenue increased 32% year-over-year to $196.3 millionQ4 net cash provided by operating activities was $18.1 million, representing 9% of revenue ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...

Purchaser coalition data show accelerating uptake: direct contracts rose from 18.7% (2023) to 27.6% (2025), with an additional 26.7% evaluating adoption over one to three years. Cost pressure remains ...

Parex Resources Inc. ("Parex" or the "Company") (TSX: PXT) is pleased to announce that it has entered into a definitive agreement (the "Arrangement ...

Maryville, Tennessee-- (Newsfile Corp. - March 5, 2026) - Smith & Wesson Brands, Inc. (NASDAQ: SWBI), a U.S.-based leader in firearm manufacturing and design, today announced financial results for the ...

Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) (TSX:BDGI) reported fourth quarter and 2025 annual results today. All results are presented in U.S. dollars unless ...

Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...